Pfizer Shares Patient Letter re Voxelotor (Oxybryta®) Withdrawal

posted 21st October 2024

Posted 3 months ago

By Pfizer

Features New Therapies Patient Guidelines Publications

21.10.2024
Pfizer shared patient advice regarding their Immediate withdrawal of voxelotor (Oxybryta®).

The NHP distributed this to their network to be shared with patients across England.

Click to view document